Area of research
Neurology · Physiology
Research interest
Research interests include Amyotrophic Lateral Sclerosis Research, Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, and Neurogenetic and Muscular Disorders Research.
Cerebrovascular Reactivity at Rest and Its Association With Cognitive Function in People With Genetic Frontotemporal Dementia
Differentiating upper- and lower motor neuron diseases using automated acoustic analysis
Thalamus involvement in genetic frontotemporal dementia assessed using structural and diffusion MRI: a GENFI study
Cellular signatures underlying functional resilience in presymptomatic frontotemporal dementia
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study
White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases
Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort
Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort
Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia
Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia
Neurodevelopmental effects of genetic frontotemporal dementia in young adult mutation carriers
Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog
Language impairment in the genetic forms of behavioural variant frontotemporal dementia
White Matter Hyperintensities and Cortical Atrophy are associated with Neuropsychiatric Symptoms in Neurodegenerative and Cerebrovascular Diseases
Characterizing the Clinical Features and Atrophy Patterns of <i>MAPT</i> -Related Frontotemporal Dementia With Disease Progression Modeling
A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of <i>Reldesemtiv</i> In Patients With ALS
Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort
Early symptoms in symptomatic and preclinical genetic frontotemporal lobar degeneration
Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study
White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study
Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial
P1‐025: Cerebral Perfusion as an Imaging Biomarker of Presymptomatic Genetic Frontotemporal Dementia: Preliminary Results from the Genetic Frontotemporal Dementia Initiative (GENFI)